Search

Sanofi announces an investment of at least one billion dollars in collaboration with Regeneron to develop new antibodies, aimed at succeeding the commercial success of Dupixent, whose global sales reached 15.7 billion euros in 2025. #Sanofi #Regeneron #Dupixent (translated)

Après le jackpot Dupixent à 15,7 milliards d'euros, Sanofi mise jusqu'à 8 milliards de dollars avec Regeneron pour trouver son prochain blockbuster

Sanofi will pay one billion dollars to Regeneron for the development of antibodies competing with Dupixent, its flagship drug that will lose exclusivity in the 2030s. #Sanofi #Regeneron #Dupixent (translated)